Periprocedural Anticoagulation Management of Patients with Thrombophilia

Ewa M. Wysokinska, Waldemar E. Wysokinski, Siva Ketha, Scott Litin, Paul Daniels, Joshua Slusser, David O. Hodge, John A. Heit, Robert D. McBane

Research output: Contribution to journalArticle

Abstract

Background Appropriate periprocedural management of the chronically anticoagulated patient with an inherited or acquired thrombophilia is uncertain. The objective of this study was to test “thrombophilia” as a potential predictor of the 3-month cumulative incidence of thromboembolism and major bleeding among chronically anticoagulated patients undergoing an invasive procedure. Methods In a prospective cohort study, consecutive chronically anticoagulated patients referred to the Mayo Thrombophilia Center for standardized periprocedural anticoagulation management who had venous thromboembolism and complete thrombophilia testing were categorized as “severe,” “non-severe,” or “no identifiable” thrombophilia. The 3-month cumulative incidence rates of thromboembolism, bleeding, and death were estimated using the Kaplan-Meier product limit method. Results Among 362 patients with complete thrombophilia testing, 165 (46%) had a defined thrombophilia; 76 patients had severe thrombophilia, mainly due to antiphospholipid syndrome (66%). Half of the patients in each of the 3 groups received pre- and postprocedure heparin. During follow-up, there were no thromboembolic events, rare major bleeding events (1% for each group), and 4 deaths. Due to the very low event rates for each of these outcomes, Cox proportional hazard modeling could not be performed. Conclusions Periprocedural event rates were low irrespective of thrombophilia status. Inherited or acquired thrombophilia was not a predictor of thromboembolism, major bleeding, or mortality after temporary interruption of chronic anticoagulation for an invasive procedure.

Original languageEnglish (US)
Pages (from-to)986-992
Number of pages7
JournalAmerican Journal of Medicine
Volume129
Issue number9
DOIs
StatePublished - Sep 1 2016

    Fingerprint

Keywords

  • Bridging
  • Periprocedural anticoagulation management
  • Thrombophilia
  • Venous thromboembolism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wysokinska, E. M., Wysokinski, W. E., Ketha, S., Litin, S., Daniels, P., Slusser, J., Hodge, D. O., Heit, J. A., & McBane, R. D. (2016). Periprocedural Anticoagulation Management of Patients with Thrombophilia. American Journal of Medicine, 129(9), 986-992. https://doi.org/10.1016/j.amjmed.2016.05.002